This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Dagmar Galter: Innovator in Parkinson's Disease Research
Introduction
Dagmar Galter is a notable inventor based in Bromma, Sweden. She has made significant contributions to the field of medical research, particularly in the identification of Parkinson's disease. Her innovative approach has the potential to improve the lives of many individuals affected by this condition.
Latest Patents
Dagmar holds a patent for a method related to identifying individuals with Parkinson's disease. The patent, titled ADH1C, describes a process for screening nucleic acids from individuals to detect mutations in the ADHC gene. This invention not only aids in diagnosis but also opens avenues for further research and treatment options.
Career Highlights
Dagmar is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her work at AstraZeneca has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Throughout her career, Dagmar has worked alongside talented colleagues, including Silvia Burvenich and Andrea Carmine. These collaborations have enriched her research and expanded the impact of her inventions.
Conclusion
Dagmar Galter's contributions to Parkinson's disease research exemplify the importance of innovation in medicine. Her work continues to inspire advancements in the field and offers hope for improved diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile